ICD-10-CM Billable Code

D3A.019

Benign carcinoid tumor of the small intestine, unspecified portion

Clinical Classification Guidelines

Medical Intelligence & Overview

A benign carcinoid tumor of the small intestine refers to a non-cancerous growth that develops from neuroendocrine cells lining the small intestine. These tumors are generally slow-growing and often discovered incidentally during evaluations for other conditions. Although benign, they require monitoring and management to prevent complications and ensure proper health care.

Causes & Symptoms

Clinical Causes: Exact causes of benign carcinoid tumors are not entirely understood. Genetic factors may play a role, with some hereditary syndromes increasing risk. Certain cumulative exposure to carcinogenic substances might contribute. Chronic inflammation or previous radiation exposure may be associated. A family history of neuroendocrine tumors can increase risk.

Key Symptoms: Digestive discomfort such as cramping or abdominal pain Occasional diarrhea or changes in bowel habits Unexplained weight loss in some cases Feeling of fullness or bloating after meals Asymptomatic in early stages, often found during imaging or endoscopy

Diagnostic & Treatment

Diagnosis Path: Imaging procedures like computed tomography (CT) scans or magnetic resonance imaging (MRI) to visualize tumors Endoscopy or capsule endoscopy to directly observe the small intestine Biopsy samples taken during endoscopy or surgery to rule out malignancy Blood and urine tests for markers such as serotonin or chromogranin A that may suggest neuroendocrine activity

Treatment Protocols: Surgical resection of the affected portion of the small intestine Monitoring through regular imaging and biochemical tests if the tumor is benign and not causing symptoms Management of symptoms such as diarrhea with appropriate medications In rare cases, targeted therapies or somatostatin analogs for tumors with active hormonal secretion Follow-up evaluations to detect any recurrence or new tumor growth

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is D3A.019 a billable ICD-10 code?
Yes, D3A.019 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report D3A.019?
Clinical documentation must specify the nature of Benign carcinoid tumor of the small intestine, unspecified portion and any associated comorbidities for accurate reporting.

Cite this Clinical Reference